OBIO icon

Orchestra BioMed
OBIO

Overview Fund Activity

48 hedge funds and large institutions have $121M invested in Orchestra BioMed in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
10
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$2.5M
2
WAM
2
Weiss Asset Management
Massachusetts
$1.15M
3
KPF
3
K2 Principal Fund
Ontario, Canada
$4.16M
4
WRBC
4
W.R. Berkley Corp
Connecticut
$1.08M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$792K

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$0
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$5M
3
LGM
3
Logos Global Management
California
$0
4
MS
4
Maven Securities
Jersey
$0
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MS
51
Maven Securities
Jersey
– – -91,715 Closed
Janus Henderson Group
52
Janus Henderson Group
United Kingdom
– – -74,049 Closed
BCP
53
Berylson Capital Partners
Massachusetts
– – -46,346 Closed
FIA
54
FNY Investment Advisers
New York
– – -5,000 Closed
CFGS
55
Concourse Financial Group Securities
Alabama
– – – –
1 2
3